Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis
The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily appl...
Saved in:
Published in: | Diabetes & metabolic syndrome clinical research & reviews Vol. 14; no. 6; pp. 2103 - 2109 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier Ltd
01-11-2020
Diabetes India. Published by Elsevier Ltd |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival.
We performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases.
Compared to a CCI score of 0, a CCI score of 1–2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity.
CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients.
•The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities.•Charlson Comorbidity Index (CCI) has been widely used as a predictor of long-term prognosis and survival.•Higher and per point increase of CCI Score is associated with poor outcomes.•CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients. |
---|---|
AbstractList | •
The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities.
•
Charlson Comorbidity Index (CCI) has been widely used as a predictor of long-term prognosis and survival.
•
Higher and per point increase of CCI Score is associated with poor outcomes.
•
CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients. The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival.BACKGROUND AND AIMSThe ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival.We performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases.METHODSWe performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases.Compared to a CCI score of 0, a CCI score of 1-2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity.RESULTSCompared to a CCI score of 0, a CCI score of 1-2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity.CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients.CONCLUSIONCCI score should be utilized for risk stratifications of hospitalized COVID-19 patients. The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival. We performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases. Compared to a CCI score of 0, a CCI score of 1–2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity. CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients. •The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities.•Charlson Comorbidity Index (CCI) has been widely used as a predictor of long-term prognosis and survival.•Higher and per point increase of CCI Score is associated with poor outcomes.•CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients. The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival. We performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases. Compared to a CCI score of 0, a CCI score of 1-2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity. CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients. |
Author | Pranata, Raymond Henrina, Joshua Lawrensia, Sherly Anthonius Lim, Michael Suastika, Ketut Tuty Kuswardhani, R.A. |
Author_xml | – sequence: 1 givenname: R.A. surname: Tuty Kuswardhani fullname: Tuty Kuswardhani, R.A. email: tutykuswardhani@yahoo.com, tutykuswardhani@unud.ac.id organization: Department of Internal Medicine, Faculty of Medicine, Udayana University, Sanglah Teaching Hospital, Denpasar- Bali, Indonesia – sequence: 2 givenname: Joshua surname: Henrina fullname: Henrina, Joshua email: joshuahenrina@gmail.com organization: RSUD Balaraja, Tangerang, Indonesia – sequence: 3 givenname: Raymond surname: Pranata fullname: Pranata, Raymond email: raymond_pranata@hotmail.com organization: Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia – sequence: 4 givenname: Michael surname: Anthonius Lim fullname: Anthonius Lim, Michael email: lim.michael.a@gmail.com organization: Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia – sequence: 5 givenname: Sherly surname: Lawrensia fullname: Lawrensia, Sherly email: sherlylawrensia@gmail.com organization: Ken Saras General Hospital, Semarang, Indonesia – sequence: 6 givenname: Ketut surname: Suastika fullname: Suastika, Ketut email: ksuas@unud.ac.id organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Udayana University Denpasar, Bali, Indonesia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33161221$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UctuFDEQtFAQecAHcEE-cpnF9jwNElK0vCJFyiXianntNvFqxh7c3iT79_FkQwQXTnZXV1e3qk7JUYgBCHnL2Yoz3n3YrizerwQTS71iQrwgJ3zoh4rVdXP0-OdVwwQ_JqeIW8baVgr5ihzXNe-4EPyE3K1vdBoxBmriFNPGW5_31AcL91QHS_WCzxF9BhodnWNMNO5yAQELja6vfl58qbiks84eQsaP9JziHjNMBTA0wa2Hu0epCbKudNDjHj2-Ji-dHhHePL1n5Prb1-v1j-ry6vvF-vyyMi3vc9UaJqHbsK5jzImNcb112tpSGdCc9dK5RrimZa0RrnONaWzb1066gQ0N7-oz8vkgO-82E1hTLkx6VHPyk057FbVX_3aCv1G_4q3qWznUPS8C758EUvy9A8xq8mhgHHWAuEMlmnaQnZBs2cUPVJMiYgL3vIYzteSltqrkpZa8FqjkVWbe_X3f88SfgArh04EAxaRiZVJois8GrE9gsrLR_0f-AZ7vqhc |
CitedBy_id | crossref_primary_10_32322_jhsm_1147178 crossref_primary_10_3390_jpm12091472 crossref_primary_10_2139_ssrn_4095318 crossref_primary_10_1097_MD_0000000000030474 crossref_primary_10_1007_s41999_023_00836_4 crossref_primary_10_12688_f1000research_108972_2 crossref_primary_10_1007_s40801_023_00360_8 crossref_primary_10_12688_f1000research_108972_1 crossref_primary_10_3390_jcm11237064 crossref_primary_10_3390_jcm10163657 crossref_primary_10_1017_dmp_2022_308 crossref_primary_10_3390_jpm11100989 crossref_primary_10_1016_j_jemermed_2024_06_004 crossref_primary_10_1590_0037_8682_0878_2020 crossref_primary_10_1038_s41467_023_38756_3 crossref_primary_10_3389_fmed_2021_670195 crossref_primary_10_1016_j_mhp_2022_200233 crossref_primary_10_3346_jkms_2024_39_e214 crossref_primary_10_4103_jfmpc_jfmpc_57_23 crossref_primary_10_1155_2023_2771149 crossref_primary_10_1080_00365521_2024_2310161 crossref_primary_10_3390_ijerph191912746 crossref_primary_10_1007_s12325_022_02293_0 crossref_primary_10_1002_jmv_29152 crossref_primary_10_1186_s12985_024_02360_8 crossref_primary_10_3390_microorganisms12040725 crossref_primary_10_3390_jcm10143112 crossref_primary_10_1186_s12874_021_01340_8 crossref_primary_10_3389_fpubh_2023_1235745 crossref_primary_10_2478_prilozi_2023_0044 crossref_primary_10_3389_fmed_2021_666949 crossref_primary_10_4081_itjm_2023_1608 crossref_primary_10_1016_j_ajem_2022_03_011 crossref_primary_10_2478_jccm_2022_0010 crossref_primary_10_3390_diagnostics12092069 crossref_primary_10_1007_s40273_023_01326_y crossref_primary_10_1371_journal_pone_0257775 crossref_primary_10_3390_jcm11071898 crossref_primary_10_3389_fmed_2022_893306 crossref_primary_10_1136_gutjnl_2020_323800 crossref_primary_10_3889_oamjms_2022_10591 crossref_primary_10_1002_ueg2_12165 crossref_primary_10_1038_s41598_021_85813_2 crossref_primary_10_3390_medicina58060769 crossref_primary_10_1093_brain_awac463 crossref_primary_10_3390_ijerph20054049 crossref_primary_10_3889_oamjms_2021_7235 crossref_primary_10_1007_s40615_022_01274_x crossref_primary_10_5005_jp_journals_10071_23946 crossref_primary_10_3390_math11132842 crossref_primary_10_4103_sjmms_sjmms_138_23 crossref_primary_10_4178_epih_e2024038 crossref_primary_10_1097_MLR_0000000000001654 crossref_primary_10_1186_s12877_022_03274_2 crossref_primary_10_7759_cureus_19690 crossref_primary_10_3390_jcm12196255 crossref_primary_10_1590_fm_2024_37112 crossref_primary_10_1016_j_ijid_2021_06_051 crossref_primary_10_3390_jpm13040628 crossref_primary_10_1080_00325481_2022_2069356 crossref_primary_10_19127_bshealthscience_1109017 crossref_primary_10_1016_j_ijregi_2022_09_007 crossref_primary_10_1016_j_ijid_2021_05_016 crossref_primary_10_1097_CCE_0000000000000662 crossref_primary_10_1136_jech_2021_216778 crossref_primary_10_3899_jrheum_220762 crossref_primary_10_21320_1818_474X_2021_3_47_60 crossref_primary_10_1111_aas_14326 crossref_primary_10_3390_vaccines11010190 crossref_primary_10_36150_2499_6564_N470 crossref_primary_10_1016_j_medcle_2023_03_025 crossref_primary_10_3390_antibiotics11111598 crossref_primary_10_3390_jcm11247413 crossref_primary_10_7759_cureus_28953 crossref_primary_10_1038_s41598_024_60733_z crossref_primary_10_1136_bmjopen_2021_054869 crossref_primary_10_1016_j_jorep_2024_100419 crossref_primary_10_3390_jcm12031042 crossref_primary_10_7759_cureus_43888 crossref_primary_10_1007_s00423_022_02495_8 crossref_primary_10_31436_ijiok_v1i1_6 crossref_primary_10_3390_ijerph19063597 crossref_primary_10_1002_agm2_12238 crossref_primary_10_3389_fragi_2022_883724 crossref_primary_10_1016_j_intimp_2021_107723 crossref_primary_10_1186_s12890_023_02807_8 crossref_primary_10_1016_j_medcli_2023_03_027 crossref_primary_10_1097_CCE_0000000000000799 crossref_primary_10_35339_ekm_2022_91_1_msh crossref_primary_10_1016_j_obmed_2021_100333 crossref_primary_10_1111_papr_13321 crossref_primary_10_4103_ijn_ijn_293_21 crossref_primary_10_1016_j_jiph_2024_03_015 crossref_primary_10_11150_kansenshogakuzasshi_96_245 crossref_primary_10_1093_cid_ciad345 crossref_primary_10_1097_MD_0000000000036777 crossref_primary_10_3390_diagnostics12122970 crossref_primary_10_3346_jkms_2023_38_e99 crossref_primary_10_5435_JAAOS_D_23_00784 crossref_primary_10_3389_fneur_2023_1125359 crossref_primary_10_1016_j_msard_2022_103964 crossref_primary_10_1111_imj_15914 crossref_primary_10_1136_bmjopen_2022_063573 crossref_primary_10_1038_s41522_022_00330_y crossref_primary_10_1093_biomethods_bpac017 crossref_primary_10_1007_s00018_021_03808_8 crossref_primary_10_7759_cureus_17255 crossref_primary_10_7759_cureus_23012 crossref_primary_10_3390_pathogens12101264 crossref_primary_10_1371_journal_pone_0243700 crossref_primary_10_3390_medicina59040657 crossref_primary_10_1016_j_bbih_2022_100425 crossref_primary_10_3390_biomedicines11030831 crossref_primary_10_1007_s11606_021_07152_2 crossref_primary_10_1016_j_ijid_2021_07_049 crossref_primary_10_1038_s41598_022_14643_7 crossref_primary_10_1186_s12889_022_13635_6 crossref_primary_10_1016_j_archger_2020_104324 crossref_primary_10_1016_j_cyto_2023_156434 crossref_primary_10_1097_MD_0000000000032343 crossref_primary_10_31436_integrationknowledge_vol1iss1_6 crossref_primary_10_3390_jpm12122037 crossref_primary_10_1186_s12931_023_02369_7 crossref_primary_10_1016_j_archger_2021_104388 crossref_primary_10_1159_000519385 crossref_primary_10_1186_s12879_024_09466_y crossref_primary_10_25122_jml_2022_0237 crossref_primary_10_26508_lsa_202201396 crossref_primary_10_1097_MEG_0000000000002091 crossref_primary_10_1186_s44158_022_00038_7 crossref_primary_10_1016_j_pan_2024_02_010 crossref_primary_10_1186_s40249_023_01057_4 crossref_primary_10_1177_10848223241235960 crossref_primary_10_4266_acc_2022_00017 crossref_primary_10_2196_41404 crossref_primary_10_3390_cancers14051173 crossref_primary_10_1016_j_mhp_2022_200247 crossref_primary_10_1186_s12877_022_03681_5 crossref_primary_10_1016_j_anr_2022_05_002 crossref_primary_10_1111_psyg_13113 crossref_primary_10_3389_fmed_2021_695195 crossref_primary_10_3389_fnut_2022_837458 crossref_primary_10_1016_j_clnesp_2021_04_001 crossref_primary_10_1186_s13019_023_02169_6 crossref_primary_10_3390_ijerph19031104 crossref_primary_10_1016_j_cmi_2023_04_028 crossref_primary_10_1177_21514593211040611 crossref_primary_10_3390_antibiotics12071124 crossref_primary_10_1016_j_gastha_2022_08_004 crossref_primary_10_3390_healthcare10020362 crossref_primary_10_3390_life11060561 crossref_primary_10_1016_j_ajem_2022_04_008 crossref_primary_10_1177_2473974X211016283 crossref_primary_10_1016_j_dsx_2021_01_003 crossref_primary_10_7759_cureus_52321 crossref_primary_10_1016_j_pcd_2021_12_008 crossref_primary_10_23736_S2784_8477_22_02007_1 crossref_primary_10_1136_bmjopen_2021_049475 crossref_primary_10_2807_1560_7917_ES_2022_27_35_2100883 crossref_primary_10_3390_biology11060937 crossref_primary_10_1093_ehjqcco_qcad074 crossref_primary_10_1177_2151459321992746 crossref_primary_10_3390_microorganisms10040806 crossref_primary_10_1016_j_dsx_2022_102395 crossref_primary_10_1089_pmr_2022_0041 crossref_primary_10_2147_IJGM_S374246 crossref_primary_10_1007_s15010_021_01699_2 crossref_primary_10_1177_10760296231219252 crossref_primary_10_1111_ped_15084 crossref_primary_10_5005_jp_journals_10071_23973 crossref_primary_10_3390_ijerph19127473 |
Cites_doi | 10.1186/1471-2288-14-135 10.1016/j.dsx.2020.06.022 10.1016/j.jstrokecerebrovasdis.2020.105185 10.1177/1753466620937175 10.1016/j.dsx.2020.08.003 10.1177/1179548420959165 10.1161/HYPERTENSIONAHA.120.15324 10.1016/j.dsx.2020.06.050 10.5588/ijtld.20.0278 10.1056/NEJMsa2011686 10.1183/13993003.00547-2020 10.1016/j.dsx.2020.06.047 10.1016/j.jstrokecerebrovasdis.2020.104949 10.1007/s11739-020-02428-7 10.1093/aje/kwq433 10.1111/joim.13119 10.1007/s10654-010-9491-z 10.1016/j.dsx.2020.03.012 10.1136/heartjnl-2013-304588 10.1038/s41430-020-0652-1 10.1681/ASN.2020040470 10.1097/MLR.0b013e318297429c 10.1177/1753466620942131 10.1016/j.ajem.2020.07.009 10.1016/j.diabet.2020.07.005 10.1016/j.phrs.2020.104931 10.1016/j.dsx.2020.04.018 10.1007/s11606-020-05991-z 10.1016/0021-9681(87)90171-8 10.1177/0962280216669183 |
ContentType | Journal Article |
Copyright | 2020 Diabetes India Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2020 Diabetes India |
Copyright_xml | – notice: 2020 Diabetes India – notice: Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. – notice: 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2020 Diabetes India |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.dsx.2020.10.022 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1878-0334 |
EndPage | 2109 |
ExternalDocumentID | 10_1016_j_dsx_2020_10_022 33161221 S1871402120304100 |
Genre | Meta-Analysis Systematic Review Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABBQC ABMAC ABMZM ABXDB ACDAQ ACGFS ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SES SSH SSZ T5K Z5R ~G- AAXKI AFJKZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c517t-5c09e6b06600f2bcf7dfadd600cea1079ff42f4505c2f6f4c4d573f9f8084163 |
ISSN | 1871-4021 1878-0334 |
IngestDate | Tue Sep 17 21:27:31 EDT 2024 Sat Oct 26 02:02:55 EDT 2024 Thu Sep 26 17:46:36 EDT 2024 Sat Nov 02 12:24:55 EDT 2024 Tue Jul 16 04:30:40 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | COVID-19 Severity Mechanical ventilation Mortality Charlson comorbidity index |
Language | English |
License | Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c517t-5c09e6b06600f2bcf7dfadd600cea1079ff42f4505c2f6f4c4d573f9f8084163 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7598371 |
PMID | 33161221 |
PQID | 2458962906 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7598371 proquest_miscellaneous_2458962906 crossref_primary_10_1016_j_dsx_2020_10_022 pubmed_primary_33161221 elsevier_sciencedirect_doi_10_1016_j_dsx_2020_10_022 |
PublicationCentury | 2000 |
PublicationDate | 2020-11-01 |
PublicationDateYYYYMMDD | 2020-11-01 |
PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Diabetes & metabolic syndrome clinical research & reviews |
PublicationTitleAlternate | Diabetes Metab Syndr |
PublicationYear | 2020 |
Publisher | Elsevier Ltd Diabetes India. Published by Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd – name: Diabetes India. Published by Elsevier Ltd |
References | Balnis, Adam, Chopra, Chieng, Feustel, Overmyer (bib14) 2020 No Title n.d. doi:10.1016/j.dsx.2020.08.003. Lim, Pranata, Huang, Yonas, Soeroto, Supriyadi (bib49) 2020; 7 Hong Kong Baptist University. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range 2020. Chroboczek, Lacoste, Wackenheim, Challan-Belval, Amar, Boisson (bib28) 2020 Gupta, Hussain, Misra (bib4) 2020 Burn, Tebe, Fernandez-Bertolin, Aragon, Recalde, Roel (bib26) 2020 Ji, Huh, Kang, Hong, Bae, Lee (bib16) 2020 Luo, Wan, Liu, Tong (bib11) 2018; 27 Marcos, Belhassen-Garcia, Sanchez- Puente, Sampedro-Gomez, Azibeiro, Dorado-Diaz (bib17) 2020 Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, et al. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study. Pharmacol Res 2020:104931. doi:10.1016/j.phrs.2020.104931. Mejia-Vilet, Cordova-Sanchez, Fernandez-Camargo, Mendez-Perez, Morales-Buenrostro, Hernandez-Gilsoul (bib18) 2020; 5 Giorgi Rossi, Ferroni, Spila Alegiani, Leoni, Pitter, Cereda (bib21) 2020 Pranata, Supriyadi, Huang, Permana, Lim, Yonas (bib50) 2020; 14 Charlson, Pompei, Ales, MacKenzie (bib6) 1987; 40 Price-Haywood, Price-Haywood, Burton, Fort, Seoane (bib20) 2020; 382 Gupta, Misra (bib5) 2020; 14 Christensen, Strange, Gislason, Torp-Pedersen, Gerds, Fosbøl (bib2) 2020 Pranata, Lim, Huang, Raharjo, Lukito (bib41) 2020; 21 Pranata, Soeroto, Ian, Lim, Santoso, Permana (bib37) 2020 Guan, Liang, Zhao, Liang, Chen, Li (bib3) 2020; 55 Lim, Pranata (bib39) 2020 Imam, Odish, Gill, O’Connor, Armstrong, Vanood (bib32) 2020 Lim, Pranata (bib44) 2020; 14 July, Pranata (bib51) 2020; 29 Pranata, Huang, Lim, Wahjoepramono, July (bib34) 2020 Pranata, Lim, Yonas, Vania, Lukito, Siswanto (bib38) 2020 Narain, Stefanov, Chau, Weber, Marder, Kaplan (bib19) 2020 World Health Organization (bib1) 2020 Regina, Papadimitriou-Olivgeris, Burger, Filippidis, Tschopp, Desgranges (bib15) 2020 Huang, Lim, Pranata (bib42) 2020; 14 Shashikumar, Wardi, Paul, Carlile, Brenner, Hibbert (bib23) 2020 Castro, Ross, McBride, Perlis (bib27) 2020 Sanchez-Montalva, Selares-Nadal, Espinosa-Pereiro, Fernandez-Hidalgo, Perez-Hoyos, Salvador (bib22) 2020 (bib13) 2020 Huang, Pranata (bib48) 2020; 8 Wan, Wang, Liu, Tong (bib10) 2014; 14 Guido, Guido, Claudio, Claudio, Massimo, Massimo (bib31) 2020; 76 Bhargava, Fukushima, Levine, Zhao, Tanveer, Szpunar (bib25) 2020; 19 Pranata, Lim, Yonas, Siswanto, Meyer (bib52) 2020; 15 Lim, Huang, Yonas, Vania, Pranata (bib36) 2020; 14 Pranata, Permana, Huang, Lim, Soetedjo, Supriyadi (bib43) 2020 Lim, Pranata (bib45) 2020 Quan, Li, Couris, Fushimi, Graham, Hider (bib8) 2011; 173 Vultaggio, Vivarelli, Virgili, Lucenteforte, Bartoloni, Nozzoli (bib24) 2020; S2213–2198 Garibaldi, Fiksel, Muschelli, Robinson, Rouhizadeh, Nagy (bib29) 2020; 5 Huang, Pranata, Lim, Oehadian, Alisjahbana (bib47) 2020; 14 Radovanovic, Seifert, Urban, Eberli, Rickli, Bertel (bib7) 2014; 100 Valeri, Robbins-Juarez, Stevens, Ahn, Rao, Radhakrishnan (bib46) 2020; 31 Austin, Wong, Uzzo, Beck, Egleston (bib33) 2015; 53 Yonas, Alwi, Pranata, Huang, Lim, Gutierrez (bib35) 2020 Stang (bib12) 2010; 25 Pranata (10.1016/j.dsx.2020.10.022_bib38) 2020 Giorgi Rossi (10.1016/j.dsx.2020.10.022_bib21) 2020 Pranata (10.1016/j.dsx.2020.10.022_bib52) 2020; 15 10.1016/j.dsx.2020.10.022_bib9 Guido (10.1016/j.dsx.2020.10.022_bib31) 2020; 76 Pranata (10.1016/j.dsx.2020.10.022_bib34) 2020 Shashikumar (10.1016/j.dsx.2020.10.022_bib23) 2020 Austin (10.1016/j.dsx.2020.10.022_bib33) 2015; 53 Marcos (10.1016/j.dsx.2020.10.022_bib17) 2020 10.1016/j.dsx.2020.10.022_bib30 Wan (10.1016/j.dsx.2020.10.022_bib10) 2014; 14 Yonas (10.1016/j.dsx.2020.10.022_bib35) 2020 Ji (10.1016/j.dsx.2020.10.022_bib16) 2020 Chroboczek (10.1016/j.dsx.2020.10.022_bib28) 2020 Narain (10.1016/j.dsx.2020.10.022_bib19) 2020 Lim (10.1016/j.dsx.2020.10.022_bib36) 2020; 14 Pranata (10.1016/j.dsx.2020.10.022_bib37) 2020 Lim (10.1016/j.dsx.2020.10.022_bib49) 2020; 7 Imam (10.1016/j.dsx.2020.10.022_bib32) 2020 Huang (10.1016/j.dsx.2020.10.022_bib42) 2020; 14 Price-Haywood (10.1016/j.dsx.2020.10.022_bib20) 2020; 382 Lim (10.1016/j.dsx.2020.10.022_bib45) 2020 Vultaggio (10.1016/j.dsx.2020.10.022_bib24) 2020; S2213–2198 Burn (10.1016/j.dsx.2020.10.022_bib26) 2020 Garibaldi (10.1016/j.dsx.2020.10.022_bib29) 2020; 5 Regina (10.1016/j.dsx.2020.10.022_bib15) 2020 Charlson (10.1016/j.dsx.2020.10.022_bib6) 1987; 40 Christensen (10.1016/j.dsx.2020.10.022_bib2) 2020 Radovanovic (10.1016/j.dsx.2020.10.022_bib7) 2014; 100 Castro (10.1016/j.dsx.2020.10.022_bib27) 2020 Bhargava (10.1016/j.dsx.2020.10.022_bib25) 2020; 19 Pranata (10.1016/j.dsx.2020.10.022_bib50) 2020; 14 Quan (10.1016/j.dsx.2020.10.022_bib8) 2011; 173 Luo (10.1016/j.dsx.2020.10.022_bib11) 2018; 27 Gupta (10.1016/j.dsx.2020.10.022_bib4) 2020 Stang (10.1016/j.dsx.2020.10.022_bib12) 2010; 25 Mejia-Vilet (10.1016/j.dsx.2020.10.022_bib18) 2020; 5 Huang (10.1016/j.dsx.2020.10.022_bib48) 2020; 8 World Health Organization (10.1016/j.dsx.2020.10.022_bib1) 2020 Sanchez-Montalva (10.1016/j.dsx.2020.10.022_bib22) 2020 Pranata (10.1016/j.dsx.2020.10.022_bib41) 2020; 21 Guan (10.1016/j.dsx.2020.10.022_bib3) 2020; 55 July (10.1016/j.dsx.2020.10.022_bib51) 2020; 29 Balnis (10.1016/j.dsx.2020.10.022_bib14) 2020 Valeri (10.1016/j.dsx.2020.10.022_bib46) 2020; 31 Huang (10.1016/j.dsx.2020.10.022_bib47) 2020; 14 Lim (10.1016/j.dsx.2020.10.022_bib39) 2020 Pranata (10.1016/j.dsx.2020.10.022_bib43) 2020 Lim (10.1016/j.dsx.2020.10.022_bib44) 2020; 14 10.1016/j.dsx.2020.10.022_bib40 Gupta (10.1016/j.dsx.2020.10.022_bib5) 2020; 14 |
References_xml | – year: 2020 ident: bib13 article-title: Review Manager (RevMan) – volume: 31 start-page: 1409 year: 2020 ident: bib46 article-title: Presentation and outcomes of patients with ESKD and COVID-19 publication-title: J Am Soc Nephrol contributor: fullname: Radhakrishnan – volume: 173 start-page: 676 year: 2011 end-page: 682 ident: bib8 article-title: Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries publication-title: Am J Epidemiol contributor: fullname: Hider – year: 2020 ident: bib1 article-title: Coronavirus disease (COVID-19) situation report – 131 contributor: fullname: World Health Organization – volume: 14 year: 2020 ident: bib47 article-title: C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis publication-title: Ther Adv Respir Dis contributor: fullname: Alisjahbana – volume: 29 year: 2020 ident: bib51 article-title: Impact of the coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: a systematic review and meta-analysis publication-title: J Stroke Cerebrovasc Dis contributor: fullname: Pranata – volume: 15 year: 2020 ident: bib52 article-title: Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic publication-title: Intern Emerg Med contributor: fullname: Meyer – volume: S2213–2198 start-page: 30611 year: 2020 end-page: 30615 ident: bib24 article-title: Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study publication-title: J. Allergy Clin. Immunol. Pract. contributor: fullname: Nozzoli – year: 2020 ident: bib39 article-title: Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture – a systematic review and meta-analysis publication-title: J Clin Orthop Trauma contributor: fullname: Pranata – year: 2020 ident: bib32 article-title: Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States publication-title: J Intern Med contributor: fullname: Vanood – year: 2020 ident: bib28 article-title: Beneficial effect of corticosteroids in severe COVID-19 pneumonia: a propensity score matching analysis publication-title: MedRxiv contributor: fullname: Boisson – year: 2020 ident: bib15 article-title: Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study publication-title: MedRxiv contributor: fullname: Desgranges – year: 2020 ident: bib19 article-title: Comparative survival analysis of immunomodulatory therapy for COVID-19 ’cytokine storm’: a retrospective observational cohort study publication-title: MedRxiv contributor: fullname: Kaplan – volume: 55 start-page: 2000547 year: 2020 ident: bib3 article-title: Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis publication-title: Eur Respir J contributor: fullname: Li – volume: 14 start-page: 135 year: 2014 ident: bib10 article-title: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range publication-title: BMC Med Res Methodol contributor: fullname: Tong – volume: 19 start-page: 1 year: 2020 end-page: 7 ident: bib25 article-title: Predictors for severe COVID-19 infection publication-title: Clin Infect Dis contributor: fullname: Szpunar – volume: 8 year: 2020 ident: bib48 article-title: Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis publication-title: J Intensive Care contributor: fullname: Pranata – year: 2020 ident: bib2 article-title: Charlson comorbidity index score and risk of severe outcome and death in Danish COVID-19 patients publication-title: J Gen Intern Med contributor: fullname: Fosbøl – volume: 25 start-page: 603 year: 2010 end-page: 605 ident: bib12 article-title: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses publication-title: Eur J Epidemiol contributor: fullname: Stang – volume: 100 start-page: 288 year: 2014 ident: bib7 article-title: Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012 publication-title: Heart contributor: fullname: Bertel – volume: 5 start-page: 20111864 year: 2020 ident: bib29 article-title: Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region publication-title: MedRxiv contributor: fullname: Nagy – year: 2020 ident: bib21 article-title: Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network publication-title: MedRxiv contributor: fullname: Cereda – start-page: 104949 year: 2020 ident: bib34 article-title: Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 – systematic review, meta-analysis, and meta-regression publication-title: J Stroke Cerebrovasc Dis contributor: fullname: July – year: 2020 ident: bib37 article-title: Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19 publication-title: Int J Tubercul Lung Dis contributor: fullname: Permana – volume: 14 start-page: 251 year: 2020 end-page: 254 ident: bib5 article-title: Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) publication-title: Diabetes Metab Syndr Clin Res Rev contributor: fullname: Misra – volume: 14 start-page: 979 year: 2020 end-page: 980 ident: bib36 article-title: A wave of non-communicable diseases following the COVID-19 pandemic publication-title: Diabetes Metab Syndr Clin Res Rev contributor: fullname: Pranata – volume: 27 start-page: 1785 year: 2018 end-page: 1805 ident: bib11 article-title: Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range publication-title: Stat Methods Med Res contributor: fullname: Tong – volume: 21 year: 2020 ident: bib41 article-title: Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression publication-title: J Renin-Angiotensin-Aldosterone Syst JRAAS contributor: fullname: Lukito – year: 2020 ident: bib23 article-title: Development and prospective validation of a transparent deep learning algorithm for predicting need for mechanical ventilation publication-title: MedRxiv. Prepr Serv. Heal Sci. contributor: fullname: Hibbert – year: 2020 ident: bib22 article-title: Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study publication-title: MedRxiv contributor: fullname: Salvador – volume: 14 start-page: 395 year: 2020 end-page: 403 ident: bib42 article-title: Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression publication-title: Diabetes Metab Syndr Clin Res Rev contributor: fullname: Pranata – volume: 382 start-page: 2534 year: 2020 end-page: 2543 ident: bib20 article-title: Hospitalization and mortality among black patients and white patients with Covid-19 publication-title: N Engl J Med contributor: fullname: Seoane – year: 2020 ident: bib4 article-title: Diabetes and COVID-19: evidence, current status and unanswered research questions publication-title: Eur J Clin Nutr contributor: fullname: Misra – volume: 7 year: 2020 ident: bib49 article-title: Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis publication-title: Can J Kidney Heal Dis contributor: fullname: Supriyadi – year: 2020 ident: bib45 article-title: The insidious threat of jamu and unregulated traditional medicines in the COVID-19 era publication-title: Diabetes Metab Syndr Clin Res Rev contributor: fullname: Pranata – year: 2020 ident: bib38 article-title: Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis publication-title: Diabetes Metab contributor: fullname: Siswanto – year: 2020 ident: bib17 article-title: Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients publication-title: MedRxiv contributor: fullname: Dorado-Diaz – year: 2020 ident: bib43 article-title: The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis publication-title: Diabetes Metab Syndr Clin Res Rev contributor: fullname: Supriyadi – volume: 5 year: 2020 ident: bib18 article-title: A risk score to predict admission to intensive care unit in patients with COVID-19: the ABC-GOALS score publication-title: MedRxiv contributor: fullname: Hernandez-Gilsoul – year: 2020 ident: bib16 article-title: Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea publication-title: MedRxiv contributor: fullname: Lee – volume: 76 start-page: 366 year: 2020 end-page: 372 ident: bib31 article-title: Age and multimorbidity predict death among COVID-19 patients publication-title: Hypertension contributor: fullname: Massimo – year: 2020 ident: bib27 article-title: Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records publication-title: MedRxiv contributor: fullname: Perlis – volume: 53 year: 2015 ident: bib33 article-title: Why summary comorbidity measures such as the Charlson comorbidity index and elixhauser score work publication-title: Med Care contributor: fullname: Egleston – year: 2020 ident: bib35 article-title: Effect of heart failure on the outcome of COVID-19 - a meta analysis and systematic review publication-title: Am J Emerg Med contributor: fullname: Gutierrez – volume: 14 year: 2020 ident: bib50 article-title: The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis publication-title: Clin Med Insights Circulatory, Respir Pulm Med contributor: fullname: Yonas – year: 2020 ident: bib26 article-title: The natural history of symptomatic COVID-19 in Catalonia, Spain: a multi-state model including 109,367 outpatient diagnoses, 18,019 hospitalisations, and 5,585 COVID-19 deaths among 5,627,520 people publication-title: MedRxiv contributor: fullname: Roel – volume: 40 start-page: 373 year: 1987 end-page: 383 ident: bib6 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chron Dis contributor: fullname: MacKenzie – year: 2020 ident: bib14 article-title: Higher plasma levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes publication-title: MedRxiv contributor: fullname: Overmyer – volume: 14 year: 2020 ident: bib44 article-title: Worrying situation regarding the use of dexamethasone for COVID-19 publication-title: Ther Adv Respir Dis contributor: fullname: Pranata – volume: 14 start-page: 135 year: 2014 ident: 10.1016/j.dsx.2020.10.022_bib10 article-title: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-135 contributor: fullname: Wan – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib45 article-title: The insidious threat of jamu and unregulated traditional medicines in the COVID-19 era publication-title: Diabetes Metab Syndr Clin Res Rev doi: 10.1016/j.dsx.2020.06.022 contributor: fullname: Lim – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib15 article-title: Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study publication-title: MedRxiv contributor: fullname: Regina – volume: 29 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib51 article-title: Impact of the coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: a systematic review and meta-analysis publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2020.105185 contributor: fullname: July – volume: 14 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib47 article-title: C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis publication-title: Ther Adv Respir Dis doi: 10.1177/1753466620937175 contributor: fullname: Huang – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib27 article-title: Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records publication-title: MedRxiv contributor: fullname: Castro – ident: 10.1016/j.dsx.2020.10.022_bib40 doi: 10.1016/j.dsx.2020.08.003 – volume: 14 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib50 article-title: The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis publication-title: Clin Med Insights Circulatory, Respir Pulm Med doi: 10.1177/1179548420959165 contributor: fullname: Pranata – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib26 article-title: The natural history of symptomatic COVID-19 in Catalonia, Spain: a multi-state model including 109,367 outpatient diagnoses, 18,019 hospitalisations, and 5,585 COVID-19 deaths among 5,627,520 people publication-title: MedRxiv contributor: fullname: Burn – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib28 article-title: Beneficial effect of corticosteroids in severe COVID-19 pneumonia: a propensity score matching analysis publication-title: MedRxiv contributor: fullname: Chroboczek – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib23 article-title: Development and prospective validation of a transparent deep learning algorithm for predicting need for mechanical ventilation publication-title: MedRxiv. Prepr Serv. Heal Sci. contributor: fullname: Shashikumar – volume: 76 start-page: 366 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib31 article-title: Age and multimorbidity predict death among COVID-19 patients publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.120.15324 contributor: fullname: Guido – volume: 14 start-page: 979 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib36 article-title: A wave of non-communicable diseases following the COVID-19 pandemic publication-title: Diabetes Metab Syndr Clin Res Rev doi: 10.1016/j.dsx.2020.06.050 contributor: fullname: Lim – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib37 article-title: Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19 publication-title: Int J Tubercul Lung Dis doi: 10.5588/ijtld.20.0278 contributor: fullname: Pranata – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib19 article-title: Comparative survival analysis of immunomodulatory therapy for COVID-19 ’cytokine storm’: a retrospective observational cohort study publication-title: MedRxiv contributor: fullname: Narain – volume: 382 start-page: 2534 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib20 article-title: Hospitalization and mortality among black patients and white patients with Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMsa2011686 contributor: fullname: Price-Haywood – volume: 55 start-page: 2000547 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib3 article-title: Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis publication-title: Eur Respir J doi: 10.1183/13993003.00547-2020 contributor: fullname: Guan – volume: S2213–2198 start-page: 30611 issue: 20 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib24 article-title: Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study publication-title: J. Allergy Clin. Immunol. Pract. contributor: fullname: Vultaggio – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib43 article-title: The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis publication-title: Diabetes Metab Syndr Clin Res Rev doi: 10.1016/j.dsx.2020.06.047 contributor: fullname: Pranata – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib1 contributor: fullname: World Health Organization – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib17 article-title: Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients publication-title: MedRxiv contributor: fullname: Marcos – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib22 article-title: Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study publication-title: MedRxiv contributor: fullname: Sanchez-Montalva – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib39 article-title: Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture – a systematic review and meta-analysis publication-title: J Clin Orthop Trauma contributor: fullname: Lim – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib14 article-title: Higher plasma levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes publication-title: MedRxiv contributor: fullname: Balnis – start-page: 104949 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib34 article-title: Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 – systematic review, meta-analysis, and meta-regression publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2020.104949 contributor: fullname: Pranata – volume: 7 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib49 article-title: Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis publication-title: Can J Kidney Heal Dis contributor: fullname: Lim – volume: 19 start-page: 1 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib25 article-title: Predictors for severe COVID-19 infection publication-title: Clin Infect Dis contributor: fullname: Bhargava – volume: 15 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib52 article-title: Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic publication-title: Intern Emerg Med doi: 10.1007/s11739-020-02428-7 contributor: fullname: Pranata – volume: 173 start-page: 676 year: 2011 ident: 10.1016/j.dsx.2020.10.022_bib8 article-title: Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries publication-title: Am J Epidemiol doi: 10.1093/aje/kwq433 contributor: fullname: Quan – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib32 article-title: Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States publication-title: J Intern Med doi: 10.1111/joim.13119 contributor: fullname: Imam – volume: 25 start-page: 603 year: 2010 ident: 10.1016/j.dsx.2020.10.022_bib12 article-title: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses publication-title: Eur J Epidemiol doi: 10.1007/s10654-010-9491-z contributor: fullname: Stang – volume: 14 start-page: 251 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib5 article-title: Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) publication-title: Diabetes Metab Syndr Clin Res Rev doi: 10.1016/j.dsx.2020.03.012 contributor: fullname: Gupta – volume: 8 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib48 article-title: Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis publication-title: J Intensive Care contributor: fullname: Huang – volume: 100 start-page: 288 year: 2014 ident: 10.1016/j.dsx.2020.10.022_bib7 article-title: Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012 publication-title: Heart doi: 10.1136/heartjnl-2013-304588 contributor: fullname: Radovanovic – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib4 article-title: Diabetes and COVID-19: evidence, current status and unanswered research questions publication-title: Eur J Clin Nutr doi: 10.1038/s41430-020-0652-1 contributor: fullname: Gupta – volume: 5 start-page: 20111864 issue: 24 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib29 article-title: Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region publication-title: MedRxiv contributor: fullname: Garibaldi – volume: 31 start-page: 1409 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib46 article-title: Presentation and outcomes of patients with ESKD and COVID-19 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2020040470 contributor: fullname: Valeri – volume: 53 year: 2015 ident: 10.1016/j.dsx.2020.10.022_bib33 article-title: Why summary comorbidity measures such as the Charlson comorbidity index and elixhauser score work publication-title: Med Care doi: 10.1097/MLR.0b013e318297429c contributor: fullname: Austin – volume: 14 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib44 article-title: Worrying situation regarding the use of dexamethasone for COVID-19 publication-title: Ther Adv Respir Dis doi: 10.1177/1753466620942131 contributor: fullname: Lim – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib35 article-title: Effect of heart failure on the outcome of COVID-19 - a meta analysis and systematic review publication-title: Am J Emerg Med doi: 10.1016/j.ajem.2020.07.009 contributor: fullname: Yonas – volume: 5 issue: 12 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib18 article-title: A risk score to predict admission to intensive care unit in patients with COVID-19: the ABC-GOALS score publication-title: MedRxiv contributor: fullname: Mejia-Vilet – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib38 article-title: Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis publication-title: Diabetes Metab doi: 10.1016/j.diabet.2020.07.005 contributor: fullname: Pranata – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib21 article-title: Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network publication-title: MedRxiv contributor: fullname: Giorgi Rossi – volume: 21 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib41 article-title: Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression publication-title: J Renin-Angiotensin-Aldosterone Syst JRAAS contributor: fullname: Pranata – ident: 10.1016/j.dsx.2020.10.022_bib30 doi: 10.1016/j.phrs.2020.104931 – volume: 14 start-page: 395 year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib42 article-title: Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression publication-title: Diabetes Metab Syndr Clin Res Rev doi: 10.1016/j.dsx.2020.04.018 contributor: fullname: Huang – ident: 10.1016/j.dsx.2020.10.022_bib9 – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib16 article-title: Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea publication-title: MedRxiv contributor: fullname: Ji – year: 2020 ident: 10.1016/j.dsx.2020.10.022_bib2 article-title: Charlson comorbidity index score and risk of severe outcome and death in Danish COVID-19 patients publication-title: J Gen Intern Med doi: 10.1007/s11606-020-05991-z contributor: fullname: Christensen – volume: 40 start-page: 373 year: 1987 ident: 10.1016/j.dsx.2020.10.022_bib6 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chron Dis doi: 10.1016/0021-9681(87)90171-8 contributor: fullname: Charlson – volume: 27 start-page: 1785 year: 2018 ident: 10.1016/j.dsx.2020.10.022_bib11 article-title: Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range publication-title: Stat Methods Med Res doi: 10.1177/0962280216669183 contributor: fullname: Luo |
SSID | ssj0055929 |
Score | 2.607977 |
SecondaryResourceType | review_article |
Snippet | The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk... • The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. • Charlson Comorbidity Index (CCI) has been widely used as a... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2103 |
SubjectTerms | Charlson comorbidity index Comorbidity - trends COVID-19 COVID-19 - diagnosis COVID-19 - mortality COVID-19 - therapy Hospitalization - trends Humans Mechanical ventilation Mortality Prospective Studies Retrospective Studies Risk Assessment - trends Severity |
Title | Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis |
URI | https://dx.doi.org/10.1016/j.dsx.2020.10.022 https://www.ncbi.nlm.nih.gov/pubmed/33161221 https://www.proquest.com/docview/2458962906 https://pubmed.ncbi.nlm.nih.gov/PMC7598371 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Li9swEBbZLJReSt-bvlChpwYHW5Yju7ewSdnd0gfdpezNyLZEslB7iWPa_vvOSJadpA_aQi8mVhRF8XwZzYxmPhHyIhageEWkvCDnCToogZdkAfOkyotIMeHHEmuHT87Fu8t4vuCLwcCd7tm3_VdJQxvIGitn_0La3aDQAK9B5nAFqcP1j-Ru9s_xWEEYvFpnqwLNbMOJaHlZTRI5ZmqZYMF1Va3HVbOBRpOZNT5-_-l07gWJI1ytben6PuGzzSP-rDbSky2tybaZO-8julPTK0P64Y4eoa_HbLmGlqZjy4zap3zAzN80Neb1Lu3RU-OPk9mkD9-W65UtaTur6mXTLTAfYP2VrVUsv8GTL_pgB1IlrJoaC7v2qwba2Ac4usFO7KMryukzoFCHgw9oUGeXONeGlYRt3NQpfr4F8F0t7odbFgHcJj9dbWzg42pS1F8nOL0J5gnaMus9Eu9znBTOieFWdOD7B-SQgWrkQ3I4O11cnjnrARw8c7Je9yPcTrzJSdz7ol_ZUj_6Svspv1s21MVtcqt1fujMovYOGajyLrnxtk3vuEe-OPDSLfBSA14KeKOSduCllaYIXurAC92oAy914H1FZ7SHLrUAM0PtQPc-uXi9uDg-8dqTQbw8CsTGi3I_UdMMzGXf1yzLtSg0LNRwlysZ-CLRmjPNwbrPmZ5qnvMiEqFOdOzjNnv4gAzLqlRHhBYqRM7JMAejjespT7I8YjKIJVdZwiM1Ii_dI06vLf9L6hIjr1KQR4rywCaQx4hwJ4S0NWCtYZoCYn73sedOYCkod9yxk6WqmjplPIqTKZ7IMCIPrQC7WYQhOGuMBSMidkTbdUDi-N13ytXSEMiLKIlDETz6t-k-Jjf7_-ITMtysG_WUHNRF86wF83cpg-jH |
link.rule.ids | 230,315,782,786,887,27934,27935 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Charlson+comorbidity+index+and+a+composite+of+poor+outcomes+in+COVID-19+patients%3A+A+systematic+review+and+meta-analysis&rft.jtitle=Diabetes+%26+metabolic+syndrome+clinical+research+%26+reviews&rft.au=Tuty+Kuswardhani%2C+R.A.&rft.au=Henrina%2C+Joshua&rft.au=Pranata%2C+Raymond&rft.au=Anthonius+Lim%2C+Michael&rft.date=2020-11-01&rft.pub=Elsevier+Ltd&rft.issn=1871-4021&rft.eissn=1878-0334&rft.volume=14&rft.issue=6&rft.spage=2103&rft.epage=2109&rft_id=info:doi/10.1016%2Fj.dsx.2020.10.022&rft.externalDocID=S1871402120304100 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1871-4021&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1871-4021&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1871-4021&client=summon |